Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hormone-Refractory Prostate Cancer × Docetaxel × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Prostatic Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Stomach Neoplasms 6 Lung Neoplasms 6 Urinary Bladder Neoplasms 5 Neoplasms 5 Carcinoma, Transitional Cell 5 Breast Neoplasms 5 Prostatic Neoplasms, Castration-Resistant 4 Non-Muscle Invasive Bladder Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2 HER2-positive Breast Cancer 2 Advanced Solid Tumors 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡